Andrea Stojakovic et al. demonstrate that partial pharmacological inhibitor of mitochondrial complex I (CP2) can reduce neurodegeneration and improve key disease phenotypes in a symptomatic mouse model of Alzheimer’s disease.
- Andrea Stojakovic
- Sergey Trushin
- Eugenia Trushina